Pulmonx Corporation
LUNG
$3.14
-$0.12-3.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 87.47M | 83.79M | 79.30M | 76.58M | 72.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 87.47M | 83.79M | 79.30M | 76.58M | 72.99M |
| Cost of Revenue | 23.21M | 21.79M | 20.49M | 19.77M | 18.75M |
| Gross Profit | 64.27M | 62.00M | 58.81M | 56.81M | 54.24M |
| SG&A Expenses | 103.88M | 102.14M | 99.55M | 98.13M | 96.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 145.20M | 141.49M | 137.51M | 135.84M | 133.06M |
| Operating Income | -57.73M | -57.70M | -58.21M | -59.25M | -60.07M |
| Income Before Tax | -56.64M | -55.89M | -56.40M | -57.29M | -58.10M |
| Income Tax Expenses | 449.00K | 500.00K | 710.00K | 577.00K | 633.00K |
| Earnings from Continuing Operations | -57.09 | -56.39 | -57.11 | -57.86 | -58.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.09M | -56.39M | -57.11M | -57.86M | -58.73M |
| EBIT | -57.73M | -57.70M | -58.21M | -59.25M | -60.07M |
| EBITDA | -55.56M | -55.39M | -55.90M | -56.93M | -58.54M |
| EPS Basic | -1.45 | -1.44 | -1.47 | -1.50 | -1.54 |
| Normalized Basic EPS | -0.90 | -0.89 | -0.91 | -0.93 | -0.95 |
| EPS Diluted | -1.45 | -1.44 | -1.47 | -1.50 | -1.54 |
| Normalized Diluted EPS | -0.90 | -0.89 | -0.91 | -0.93 | -0.95 |
| Average Basic Shares Outstanding | 157.76M | 156.44M | 155.23M | 154.08M | 152.95M |
| Average Diluted Shares Outstanding | 157.76M | 156.44M | 155.23M | 154.08M | 152.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |